CUREVAC NV revenue breakdown overview

CUREVAC NV revenue for the last year amounted to 503.18 M CHF, the most of which — 525.76 M CHF — came from its highest performing source at the moment, Transformative Medicines, the year earlier bringing 48.93 M CHF. The greatest contribution to the revenue figure was made by Belgium — last year it brought CUREVAC NV 510.70 M CHF, and the year before that — 42.90 M CHF.